Bank of America’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $78K | Buy |
|
|||||
|
2025
Q2 | $30.3K | Sell |
|
|||||
|
2025
Q1 | $44.3K | Sell |
|
|||||
|
2024
Q4 | $101K | Buy |
|
|||||
|
2024
Q3 | $168K | Buy |
|
|||||
|
2024
Q2 | $146K | Buy |
|
|||||
|
2024
Q1 | $206K | Sell |
|
|||||
|
2023
Q4 | $322K | Buy |
|
|||||
|
2023
Q3 | $179K | Buy |
|
|||||
|
2023
Q2 | $179K | Buy |
|
|||||
|
2023
Q1 | $148K | Sell |
|
|||||
|
2022
Q4 | $119K | Sell |
|
|||||
|
2022
Q3 | $264K | Buy |
|
|||||
|
2022
Q2 | $71K | Sell |
|
|||||
|
2022
Q1 | $97K | Sell |
|
|||||
|
2021
Q4 | $1.09M | Buy |
|
|||||
|
2021
Q3 | $91K | Sell |
|
|||||
|
2021
Q2 | $153K | Sell |
|
|||||
|
2021
Q1 | $1.07M | Buy |
|
|||||
|
2020
Q4 | $274K | Sell |
|
|||||
|
2020
Q3 | $254K | Buy |
|
|||||
|
2020
Q2 | $154K | Buy |
|
|||||
|
2020
Q1 | $71K | Sell |
|
|||||
|
2019
Q4 | $248K | Sell |
|
|||||
|
2019
Q3 | $542K | Sell |
|
|||||
|
2019
Q2 | $1.75M | Sell |
|
|||||
|
2019
Q1 | $2.06M | Buy |
|
|||||
|
2018
Q4 | $220K | Sell |
|
|||||
|
2018
Q3 | $581K | Sell |
|
|||||
|
2018
Q2 | $1.05M | Buy |
|
|||||
|
2018
Q1 | $714K | Sell |
|
|||||
|
2017
Q4 | $1.71M | Sell |
|
|||||
|
2017
Q3 | $7.63M | Buy |
|
|||||
|
2017
Q2 | $3.46M | Sell |
|
|||||
|
2017
Q1 | $5.61M | Buy |
|
|||||
|
2016
Q4 | $3.48M | Buy |
|
|||||
|
2016
Q3 | $3.55M | Sell |
|
|||||
|
2016
Q2 | $2.85M | Buy |
|
|||||
|
2016
Q1 | $2.32M | Buy |
|
|||||
|
2015
Q4 | $865K | Buy |
|
|||||
|
2015
Q3 | $639K | Buy |
|
|||||
|
2015
Q2 | $159K | Buy |
|
|||||
|
2015
Q1 | $111K | Buy |
|
|||||
|
2014
Q4 | $105K | Buy |
|
|||||
|
2014
Q3 | $151K | Sell |
|
|||||
|
2014
Q2 | $447K | Sell |
|
|||||
|
2014
Q1 | $487K | Sell |
|
|||||
|
2013
Q4 | $573K | Sell |
|
|||||
|
2013
Q3 | $821K | Buy |
|
|||||
|
2013
Q2 | $697K | Buy |
|